newsfilter
← Latest News
GlobeNewswire·

SCYNEXIS Announces One-for-Eight Reverse Stock Split

JERSEY CITY, N.J., May 22, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ:SCYX) ("SCYNEXIS"), a clinical-stage biotechnology company dedicated to advancing innovative solutions for severe rare diseases, today